miR-5089-5p suppresses castration-resistant prostate cancer resistance to enzalutamide and metastasis via miR-5089-5p/SPINK1/ MAPK/MMP9 signaling
- Type
- Retraction
- Notice date
- 10/31/2020 0:00
- Journal
- Aging
- Publisher
- Impact Journals
- Notice DOI
- 10.18632/aging.104212
- Original paper DOI
- 10.18632/aging.103485